Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)‐positive blood products to Rh(D)‐negative children
- 23 June 2021
- journal article
- letter
- Published by Wiley in Vox Sanguinis
- Vol. 117 (2) , 291-292
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Life-Threatening Bleeding in Children: A Prospective Observational StudyCritical Care Medicine, 2021
- The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusionVox Sanguinis, 2021
- Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature reviewHematology, 2021
- Transfusion-Related Alloimmunization to Red Blood Cell Antigens in Japanese Pediatric RecipientsTransfusion Medicine Reviews, 2021
- Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort studyThe Lancet Haematology, 2016